Ludivine is a Director in Medical Affairs at Pfizer within the Inflammation and Immunology Business Unit. She is part the US Landscape and Patient Excellence team which has a mission to innovate our Medical Affairs activities to improve patient outcomes. She is an epidemiologist by training. Starting her career in the Academia as an academic researcher and professor assistant at Laval University, Quebec, Canada., she transitioned to Pharmaceutical Industry having held roles in both Research Development and Medical Affairs.

Kelly H. Zou, Ph.D., PStat® is Head of Global Medical Analytics and Real World Evidence, Viatris. She is an elected Fellow of the American Statistical Association and an Accredited Professional Statistician. Previously at Pfizer Inc, she was Vice President and Head of Medical Analytics & Insights; Senior Director of Real World Evidence, Group Lead of Methods & Algorithms and Analytic Science Lead; Senior Director of Statistics. She was Associate Professor of Radiology at Harvard Medical School, as well as Director of Biostatistics at its affiliated teaching hospitals. She was Associate Director of Rates at Barclays Capital. She received both MA and PhD degrees in Statistics from the University of Rochester. She completed her Postdoctoral Fellowship at Harvard. Her research interests include health policy, real world evidence, signal detection, and artificial intelligence, with over 160 professional articles and 5 books. She was featured as an Outstanding Woman in Data Analytics by Forbes, an Inspirational Women in Statistics & Data Science by Wiley and the Royal Statistical Society, and an Accomplished Woman in Statistics and Data Science by the American Statistical Association.

Experienced Health Data Lead, Roche, with long background Life Science within strategic Market Access, RWD (e), HTA and Negotiation. Background in public healthcare and healthcare incentive-structures.

Dr. Ignacio H. Medrano is a Consultant Neurologist with training in
Healthcare Management and experience in Clinical research
strategies (formerly responsible for +500 researchers).
A Singularity University graduate, he is a founder at Mendelian in
the UK (AI for diagnose of rare diseases) and at Savana (Real
World Evidence using AI on Electronic Medical Records).
In 2021 Forbes praised Dr Ignacio H. Medrano, including
him in the list of the 100 most creative Spaniards in the business
world.
From the European Commision to the British Royal Academy of
Science, Ignacio is a well-known international speaker.

Chris Rolfe is a consultant in Real-World Evidence, located in the Marlow, UK office. Chris is responsible for commercial and scientific consultancy, identifying, generating and converting new business development opportunities, and account management of OPEN Health’s clients.​

Having previously owned the entire lifecycle of quantitative insight solutions within the Wilmington Healthcare portfolio, he has worked with many of the top 50 pharma companies, developing a reputation for converting complex customer challenges into easy to interpret, actionable insight.​

Perceived as an expert in the use of HES, MHLDDS, QOF, GP prescribing and Public Health datasets to produce innovative, compliant products that improve health and social care outcomes.​

Experienced in ensuring critical activities and solutions are delivered within ISO27001 and ISO9001 information security and quality frameworks, whilst managing the relationship with NHS Digital to demonstrate true value in compliantly delivering benefit to the healthcare sector.​

Tove is a professor of health economic evidence at the University of Ghent.

Tove has more than 20 years pharmaceutical experience in the field of health economics, outcome research, and evidence based documentation of health improvements. 

Dr Rujuta Sanap is a healthcare professional specializing in Health Sciences, Public Health Management, Health policy and Health Economics. At Google Cloud, she works on solving real-world problems with data-powered innovation and technology as a Customer Engineer focussed on Global Public Sector, Healthcare and Life Sciences. Before Google, she worked as a senior consultant at IQVIA and gained 5+ years of experience in social media analytics, HEOR, research and consulting across healthcare and pharmaceuticals markets globally. Her academic research has been focused on social health insurance, universal healthcare, health impact of trade policies and behavioral economics. She holds an MSc in International Health Policy and Health Economics from the London School of Economics and Political Science, an MBA in Health Management from Institute of Health Management Research and a baccalaureate in Health Sciences and Dental Surgery.

An experienced Sales leader with more than 18 years’ experience in Solution Sales working with companies such as Andor Technology; General Electric; Oracle, Microsoft and recently Google Cloud.

My main focus is helping organisations transform digitally with an emphasis on data driven digital transformation . 

More recently Raymond Hounon has been working with customers to develop their Digital transformation strategies by modernising their Data platform and innovating, automating business processes by leveraging new data analytics; data engineering ; CI-CD tools and AI / ML solutions. 

The focus has typically been towards Google Cloud platform and Microsoft Azure data services; as companies see the growing benefits for a Cloud based delivery model to that of traditional ‘On Premise’ models. 

Areas of interest to Raymond Hounon are: Big Data; Cognitive services; IoT; Advanced Analytics & AI/ML; infrastructure as a code; mobile etc.…..